• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

半胱氨酸蛋白酶克鲁兹蛋白酶特异性的结构决定因素。

Structural determinants of specificity in the cysteine protease cruzain.

作者信息

Gillmor S A, Craik C S, Fletterick R J

机构信息

Graduate Group in Biophysics, University of California, San Francisco 94143-0448, USA.

出版信息

Protein Sci. 1997 Aug;6(8):1603-11. doi: 10.1002/pro.5560060801.

DOI:10.1002/pro.5560060801
PMID:9260273
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2143760/
Abstract

The structure of cruzain, an essential protease from the parasite Trypanosoma cruzi, was determined by X-ray crystallography bound to two different covalent inhibitors. The cruzain S2 specificity pocket is able to productively bind both arginine and phenylalanine residues. The structures of cruzain bound to benzoyl-Arg-Ala-fluoromethyl ketone and benzoyl-Tyr-Ala-fluoromethyl ketone at 2.2 and 2.1 A, respectively, show a pH-dependent specificity switch. Glu 205 adjusts to restructure the S2 specificity pocket, conferring right binding to both hydrophobic and basic residues. Kinetic analysis of activated peptide substrates shows that substrates placing hydrophobic residues in the specificity pocket are cleaved at a broader pH range than hydrophilic substrates. These results demonstrate how cruzain binds both basic and hydrophobic residues and could be important for in vivo regulation of cruzain activity.

摘要

克氏锥虫(Trypanosoma cruzi)的一种必需蛋白酶——克氏锥虫蛋白酶(cruzain)的结构,通过与两种不同的共价抑制剂结合的X射线晶体学方法得以确定。克氏锥虫蛋白酶的S2特异性口袋能够有效地结合精氨酸和苯丙氨酸残基。分别在2.2 Å和2.1 Å分辨率下,克氏锥虫蛋白酶与苯甲酰-精氨酸-丙氨酸氟甲基酮和苯甲酰-酪氨酸-丙氨酸氟甲基酮结合的结构显示出pH依赖性的特异性转换。谷氨酸205进行调整以重构S2特异性口袋,赋予对疏水和碱性残基的正确结合。对活化肽底物的动力学分析表明,在特异性口袋中放置疏水残基的底物比亲水底物在更宽的pH范围内被切割。这些结果证明了克氏锥虫蛋白酶如何结合碱性和疏水残基,并且对于克氏锥虫蛋白酶活性的体内调节可能很重要。

相似文献

1
Structural determinants of specificity in the cysteine protease cruzain.半胱氨酸蛋白酶克鲁兹蛋白酶特异性的结构决定因素。
Protein Sci. 1997 Aug;6(8):1603-11. doi: 10.1002/pro.5560060801.
2
Subsite specificity of trypanosomal cathepsin L-like cysteine proteases. Probing the S2 pocket with phenylalanine-derived amino acids.锥虫组织蛋白酶L样半胱氨酸蛋白酶的亚位点特异性。用苯丙氨酸衍生的氨基酸探测S2口袋。
Eur J Biochem. 2001 May;268(9):2733-41. doi: 10.1046/j.1432-1327.2001.02172.x.
3
Crystal structures of reversible ketone-Based inhibitors of the cysteine protease cruzain.半胱氨酸蛋白酶克鲁兹蛋白酶的可逆酮基抑制剂的晶体结构
Bioorg Med Chem. 2003 Jan 2;11(1):21-9. doi: 10.1016/s0968-0896(02)00427-3.
4
Structure-based design, synthesis and evaluation of conformationally constrained cysteine protease inhibitors.基于结构的构象受限半胱氨酸蛋白酶抑制剂的设计、合成与评价
Bioorg Med Chem. 1998 Dec;6(12):2477-94. doi: 10.1016/s0968-0896(98)80022-9.
5
Probing the cruzain S2 recognition subsite: a kinetic and binding energy calculation study.探究克鲁斯蛋白酶S2识别亚位点:动力学与结合能计算研究
Biochemistry. 2005 Mar 1;44(8):2781-9. doi: 10.1021/bi048417v.
6
Development of alpha-keto-based inhibitors of cruzain, a cysteine protease implicated in Chagas disease.开发基于α-酮的克氏锥虫蛋白酶抑制剂,该蛋白酶是一种与恰加斯病相关的半胱氨酸蛋白酶。
Bioorg Med Chem. 2005 Mar 15;13(6):2141-56. doi: 10.1016/j.bmc.2004.12.053.
7
Production of crystallizable cruzain, the major cysteine protease from Trypanosoma cruzi.可结晶克氏锥虫半胱氨酸蛋白酶(克氏锥虫主要的半胱氨酸蛋白酶)的生产。
J Biol Chem. 1993 Mar 25;268(9):6115-8.
8
Crystal structure of chagasin, the endogenous cysteine-protease inhibitor from Trypanosoma cruzi.恰加斯因(来自克氏锥虫的内源性半胱氨酸蛋白酶抑制剂)的晶体结构。
J Struct Biol. 2007 Feb;157(2):416-23. doi: 10.1016/j.jsb.2006.07.017. Epub 2006 Aug 17.
9
S1 subsite specificity of a recombinant cysteine proteinase, CPB, of Leishmania mexicana compared with cruzain, human cathepsin L and papain using substrates containing non-natural basic amino acids.利用含有非天然碱性氨基酸的底物,比较墨西哥利什曼原虫的重组半胱氨酸蛋白酶CPB与克氏锥虫蛋白酶、人组织蛋白酶L和木瓜蛋白酶的S1亚位点特异性。
Eur J Biochem. 2001 Mar;268(5):1206-12. doi: 10.1046/j.1432-1327.2001.01973.x.
10
Catalytic Mechanism of Cruzain from Trypanosoma cruzi As Determined from Solvent Kinetic Isotope Effects of Steady-State and Pre-Steady-State Kinetics.从稳态和预稳态动力学的溶剂动力学同位素效应确定的克氏锥虫克鲁斯蛋白酶的催化机制
Biochemistry. 2018 Jun 5;57(22):3176-3190. doi: 10.1021/acs.biochem.7b01250. Epub 2018 Feb 2.

引用本文的文献

1
Unraveling Common Patterns and Differences among Cruzipains through Molecular Dynamics Simulations and Structural Analyses.通过分子动力学模拟和结构分析揭示克鲁兹蛋白酶之间的常见模式和差异
ACS Omega. 2025 May 2;10(18):19115-19128. doi: 10.1021/acsomega.5c01876. eCollection 2025 May 13.
2
Exploring Lamiaceae diterpenoids as potential multitarget therapeutics for leishmaniasis and chagas disease.探索唇形科二萜类化合物作为治疗利什曼病和恰加斯病的潜在多靶点疗法。
Mol Divers. 2025 Apr 26. doi: 10.1007/s11030-025-11200-y.
3
Exploring the Anti-Chagas Activity of 's Seedlings Through Metabolomics and Protein-Ligand Docking.通过代谢组学和蛋白质-配体对接探索[植物名称]幼苗的抗恰加斯病活性 。 (注:原文中“'s Seedlings”这里的植物名称缺失,翻译时用[植物名称]表示)
Plants (Basel). 2025 Mar 18;14(6):954. doi: 10.3390/plants14060954.
4
Anti-Trypanosomal Bufadienolides from the Oocytes of the Toad (Anura, Bufonidae).蟾酥中抗锥虫的蟾毒内酯(有尾目,蟾蜍科)。
Molecules. 2023 Dec 29;29(1):196. doi: 10.3390/molecules29010196.
5
Microwave-assisted hydrothermal fabrication of hierarchical-stacked mesoporous decavanadate-intercalated ZnAl nanolayered double hydroxide to exterminate different developmental stages of and .微波辅助水热法制备分级堆叠的介孔十钒酸盐插层ZnAl纳米层状双氢氧化物以杀灭[具体物种1]和[具体物种2]的不同发育阶段。
Heliyon. 2023 Jul 8;9(7):e18110. doi: 10.1016/j.heliyon.2023.e18110. eCollection 2023 Jul.
6
Targeting Cysteine Proteases and their Inhibitors to Combat Trypanosomiasis.靶向半胱氨酸蛋白酶及其抑制剂以对抗锥虫病。
Curr Med Chem. 2024;31(16):2135-2169. doi: 10.2174/0929867330666230619160509.
7
ACW-02 an Acridine Triazolidine Derivative Presents Antileishmanial Activity Mediated by DNA Interaction and Immunomodulation.ACW-02,一种吖啶三唑烷衍生物,通过DNA相互作用和免疫调节介导呈现抗利什曼原虫活性。
Pharmaceuticals (Basel). 2023 Jan 29;16(2):204. doi: 10.3390/ph16020204.
8
Structure determinants defining the specificity of papain-like cysteine proteases.决定木瓜蛋白酶样半胱氨酸蛋白酶特异性的结构决定因素。
Comput Struct Biotechnol J. 2022 Nov 24;20:6552-6569. doi: 10.1016/j.csbj.2022.11.040. eCollection 2022.
9
Proteases and HPV-Induced Carcinogenesis.蛋白酶与HPV诱导的致癌作用
Cancers (Basel). 2022 Jun 21;14(13):3038. doi: 10.3390/cancers14133038.
10
The gene repertoire of the main cysteine protease of Trypanosoma cruzi, cruzipain, reveals four sub-types with distinct active sites.克氏锥虫主要半胱氨酸蛋白酶(cruzipain)的基因库揭示了具有不同活性位点的四个亚型。
Sci Rep. 2021 Sep 14;11(1):18231. doi: 10.1038/s41598-021-97490-2.

本文引用的文献

1
Crystallographic R factor refinement by molecular dynamics.利用分子动力学进行晶体学 R 因子精修。
Science. 1987 Jan 23;235(4787):458-60. doi: 10.1126/science.235.4787.458.
2
The 1.8 A crystal structure of human cathepsin G in complex with Suc-Val-Pro-PheP-(OPh)2: a Janus-faced proteinase with two opposite specificities.人组织蛋白酶G与Suc-Val-Pro-PheP-(OPh)2复合物的1.8埃晶体结构:一种具有两种相反特异性的双面蛋白酶。
EMBO J. 1996 Oct 15;15(20):5481-91.
3
Structure of rat procathepsin B: model for inhibition of cysteine protease activity by the proregion.大鼠组织蛋白酶B前体的结构:前结构域对半胱氨酸蛋白酶活性的抑制模型
Structure. 1996 Apr 15;4(4):405-16. doi: 10.1016/s0969-2126(96)00046-9.
4
Engineering the S2 subsite specificity of human cathepsin S to a cathepsin L- and cathepsin B-like specificity.将人组织蛋白酶S的S2亚位点特异性改造为组织蛋白酶L和组织蛋白酶B样特异性。
J Biol Chem. 1994 Dec 2;269(48):30238-42.
5
Crystal structures of recombinant rat cathepsin B and a cathepsin B-inhibitor complex. Implications for structure-based inhibitor design.重组大鼠组织蛋白酶B及组织蛋白酶B-抑制剂复合物的晶体结构。对基于结构的抑制剂设计的启示。
J Biol Chem. 1995 Mar 10;270(10):5527-33. doi: 10.1074/jbc.270.10.5527.
6
Alignment/phylogeny of the papain superfamily of cysteine proteases.半胱氨酸蛋白酶木瓜蛋白酶超家族的比对/系统发育
J Mol Biol. 1995 Feb 17;246(2):273-83. doi: 10.1006/jmbi.1994.0083.
7
Structural basis of substrate specificity in the serine proteases.丝氨酸蛋白酶底物特异性的结构基础。
Protein Sci. 1995 Mar;4(3):337-60. doi: 10.1002/pro.5560040301.
8
Crystal structure of cathepsin B inhibited with CA030 at 2.0-A resolution: A basis for the design of specific epoxysuccinyl inhibitors.CA030抑制组织蛋白酶B的2.0埃分辨率晶体结构:特异性环氧琥珀酰抑制剂设计的基础
Biochemistry. 1995 Apr 11;34(14):4791-7. doi: 10.1021/bi00014a037.
9
Cathepsin B, Cathepsin H, and cathepsin L.组织蛋白酶B、组织蛋白酶H和组织蛋白酶L。
Methods Enzymol. 1981;80 Pt C:535-61. doi: 10.1016/s0076-6879(81)80043-2.
10
Redesigning trypsin: alteration of substrate specificity.重新设计胰蛋白酶:底物特异性的改变
Science. 1985 Apr 19;228(4697):291-7. doi: 10.1126/science.3838593.